OBJECTIVE: Using angiography, this study examined left atrial appendage (LAA) morphology in Chinese patients with atrial fibrillation (AF) or congenital atrial septal defects (ASD), to provide data that might aid the design of new LAA-occluding devices to prevent cardioembolism and stroke in patients with AF. METHODS: Patients with AF or ASD were enrolled. The LAA was visualized angiographically; its dimensions were measured and the emptying fraction was calculated. RESULTS: A total of 45 patients with AF and 30 patients with ASD were included in the study. LAA morphology was classified into eight categories. The majority of patients with AF had tube-shaped LAAs with a single lobe; the most common LAA morphologies in patients with ASD were irregular or sphere-like, with multiple lobes. Patients with AF had significantly larger LAAs with significantly lower emptying fractions compared with LAAs of patients with ASD. CONCLUSIONS: The LAA demonstrated considerable morphological variability in terms of its size, shape and number of lobes. The design of new occluding devices must take into account the size and shape of the LAA in patients with AF.
Introduction
The left atrial appendage (LAA) is the most important source of cardiac systemic embolic events, particularly in patients with atrial fibrillation (AF). 1 Several devices to treat percutaneous transcatheter occlusion of the LAA, in patients with AF at high risk of stroke and unable to take warfarin, have been evaluated. For example, percutaneous LAA transcatheter occlusion using the PLAATO™ device (Appriva Medical, Sunnyvale, CA, USA), which is a self-expanding, membrane-covered spherical nitinol cage, 2,3 the Amplatzer ® device (AGA Medical, Golden Valley, MN, USA), 4 and the Watchman ® LAA Filter System 5 (Atritech, Plymouth, MN, USA) have all been designed for the catheter-based closure of the LAA, to avoid systemic thromboembolism. We investigated the Amplatzer ® device for occlusion of the LAA in a swine model and found that it would not fix stably in the LAA (unpublished data). Although the anatomy of the LAA has been described, 6,7 there has been no angiographic Morphological variability of LAA in AF patients study of the shape and size of the LAA in patients with AF. The present study investigated the morphology of the LAA in Chinese patients with AF or congenital atrial septal defects (ASD) using angiography, in order to assist with the development of new occluding devices that can be stably fixed in the LAA.
Patients and methods

STUDY POPULATION
Consecutive patients were enrolled in this study, which took place between 13 January 2005 and 25 March 2006 in the Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China. Before patients underwent angiography procedures, transoesophageal echocardiography examinations were performed using the GE Vivid 7 ultrasound machine (GE Healthcare Biosciences, Piscataway, NJ, USA) equipped with a multiplane transoesophageal probe, to exclude patients with LAA thrombi. Other exclusion criteria were: malignant tumours or other diseases at the terminal stage; the occurrence of myocardial infarction or thromboembolic events within 3 months; unwillingness to provide informed consent. Patients were divided into two groups: those with either paroxysmal or persistent AF but with no symptoms of structural heart disease; those with congenital ASD, all of whom had ostium secundum defects without AF.
Written informed consent was obtained from each patient prior to study inclusion. The study protocol was approved by the Ethical Committee at the First Affiliated Hospital of Nanjing Medical University. The trial was registered with ClinicalTrials.gov (Protocol ID: CARD10-001).
CATHETERIZATION PROCEDURE
After the application of local anaesthesia and right femoral venous access, the left atrium was approached using a standard trans-septal puncture in patients with AF; those with ASD did not require trans-septal puncture. After trans-septal catheterization (8F sheath, SL1; St Jude Medical, St Paul, MN, USA) under radioscopic guidance, heparin (Changzhou Qianhong Bio-pharma, Changzhou, China) was administered intravenously to maintain an activated clotting time of 250 -300 s: 5000 IU of heparin were administered initially, then the dose was adjusted according to the activated clotting time. Next, the 8F sheath SL1 was advanced to the orifice of the LAA. The LAA was examined by manually injecting 8 -10 ml of the X-ray contrast agent iopromide (Schering Pharmaceuticals, Guangzhou, China) in the 30° right anterior oblique. At least three cardiac cycles were recorded. All patients were treated with either radiofrequency catheter ablation of AF or catheter closure of the secundum atrial septal defect after LAA angiography.
POSTCATHETERIZATION
OBSERVATIONS AND MEASUREMENTS
Postcatheterization observations and measurements were performed in the catheterization laboratory at The First Affiliated Hospital of Nanjing Medical University. The 8F sheath SL1, was used as the standard reference, to categorize the LAA according to the number of lobes and the shape of the LAA body, by measuring the following parameters: orifice diameter (from the inferior to the superior junction of the left atrium and the LAA); length (curvilinear distance from the middle of the orifice to the end of the tail); width (maximal straight-line measurement); height of the neck (vertical dimension from the orifice line to the point where the direction changes to the blind-Morphological variability of LAA in AF patients ending sac of the main tubular body); inner diameter (distance from the inferior border to the superior border of the bent tubular body; Fig. 1 ). Maximum and minimum areas of the LAA were measured by manual planimetry. The LAA emptying fraction was calculated from the formula: (maximum areaminimum area)/maximum area.
STATISTICAL ANALYSES
The results were expressed as mean ± SD. All statistical analyses were performed using the SPSS ® statistical package, version 10.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . The value was obtained from the mean of the three measurements in the systolic phase.
An unpaired t-test was used to compare the two groups of patients. Differences were considered to be statistically significant if the null hypothesis could be rejected with > 95% confidence (P-value < 0.05). All P-values were two-tailed.
Results
In total, 100 consecutive patients were enrolled in the study, 25 of whom were excluded because of the presence of emboli in the LAA. The remaining 75 patients were divided into two groups: 45 patients (33 men, 12 women; mean age ± SD, 50.6 ± 9.6 years) with either paroxysmal (n = 34) or persistent AF (n = 11); and 30 patients (nine men, 21 women; mean age ± SD, 28.6 ± 15.1 years) with congenital ASD. Symptom onset ranged between 2 months and 36 years for the overall study population.
Based on the angiographic observations and measurements, the LAA were divided into eight categories that characterized different shapes of the main body and different numbers of lobes (single, two or multiple) (Figs 1 and 2; Table 1 ). Table 1 also shows the distribution of the shapes in the two groups of patients. In patients with AF, tube-shaped LAAs were the most common Data presented as n (%). a LAA shapes (main body): tube, looks like a cylinder with no lobe; claw, looks like a claw with multiple lobes; sphere-like, looks like a ball; tadpole, looks like a tail with a bigger lobe; willow-leaf, triangular (looks like a willow leaf); sword, looks like a sword with no lobe; duckbill, looks like an open duckbill with two lobes; irregular, cannot be classified as described above. Morphological variability of LAA in AF patients 60%); in patients with ASD, the LAA was most likely to have two lobes (13/30; 43%). Significant differences between the two groups were not compared. Table  2 presents the physical measurements of the LAA dimensions for each group of patients. The mean orifice diameter, length, width, height and inner diameter of the LAA in patients with AF were significantly larger than the equivalent measurements in patients with ASD (P < 0.001 for each comparison). Both the maximum and minimum areas in patients with AF were significantly larger than those in patients with ASD (P < 0.001 for both comparisons). The mean emptying fraction of the LAA in patients with AF was significantly lower than that in patients with ASD (33.6 ± 0.1% and 41.1 ± 0.1% respectively; P < 0.001).
Discussion
The LAA has been described as a long, narrow, tubular, wavy, hooked appendage with a narrow junction and crenulated lumen. 6,7 It is a small, muscular extension of the left atrium that lies in the left atrioventricular sulcus, on top of the proximal portion of the left circumflex artery. Emboli that form in the LAA are reported to be the main causes of stroke in patients with AF. 1 In patients with nonvalvular AF, 91% of atrial thrombi are located in the LAA, almost always in the distal, trabeculated portion. 1, 8 It is important to improve knowledge of the morphology of the LAA in order to design new LAA-occluding devices. Various methods have been used to study LAA morphology, such as transoesophageal echo cardiography, 9 cardiac computed tomography (CT) scanning 10 and magnetic resonance imaging (MRI). 11 Normal LAA morphology has also been studied using autopsy heart specimens. 12 Transoesophageal echocardiography is a safe and convenient noninvasive imaging method. Unfortunately, this technique only provides a way to visualize the structure of the LAA by two-dimensional imaging of this small blind-ended cavity, whereas lobes often exist in different planes. 12 Cardiac CT scanning or MRI can also visualize the shape of the LAA noninvasively, but these techniques cannot detect any dynamic changes of the LAA. 10, 11 Based on the angiographic examinations that were undertaken in the present study, eight categories of LAA were defined which Orifice diameter, mm 12.0 ± 2.5 20.9 ± 2.9*** Length, mm
28.5 ± 6.5 40.4 ± 5.7*** Width, mm 14.6 ± 3.6 21.1 ± 4.1*** Height, mm 3.1 ± 0. In patients with AF, the most common shape was tube-shaped with a single lobe, whereas irregular and sphere-like shapes (with two or more lobes) were more commonly observed in patients with ASD. Based on physical measurements of the LAA, patients with AF had significantly larger LAA than patients with ASD. The mean orifice diameter, length, width, height, inner diameter, maximum area and minimum area of the LAA in patients with AF were significantly larger than in patients with ASD. In contrast, the mean LAA emptying fraction was significantly lower in patients with AF than in patients with ASD. These morphological changes may result from the haemodynamic changes associated with AF. Atrial enlargement is a well-known change that occurs in patients with AF. 13 -15 It has also been reported that left atrial enlargement may be a cause, rather than a consequence, of AF. 16 Successful radiofrequency ablation in patients with AF results in a decrease in left atrial diameter. 17 Left atrial size and pressure may be related to the dimensions of the LAA. As left atrial size appears to be associated with AF, patients with congenitally larger LAAs might be at increased risk of AF, and AF could lead to a larger left atrium and LAA dimension. In the patients with ASD in the present study, most cases had sphere-like or irregular-shaped LAAs with two or more lobes, which might be related to the congenital heart defects. The contractile function of the LAA has received considerable attention and a reduced emptying fraction partly accounts for the fact that the majority of cardiac emboli form in the LAA. 18, 19 The mean emptying fraction of LAAs in patients with AF was significantly lower than that in patients with ASD in the present study.
The major and potentially fatal risk for patients with AF is the development of systemic thromboembolism resulting in stroke. 20 The LAA is the most important source of cardioembolic events and LAA occlusion is a promising technique for stroke prevention, 21 but it can result in pulmonary vein stenosis as a result of displacement of the occluding device. Serious cardiac arrhythmia may develop if the occluding device slips into the left atrium.
The present study has provided detailed morphological data on LAAs in patients with AF that might be useful for the design of new occluding devices that can be stably fixed in LAAs to provide effective occlusion while avoiding complications. Regarding the design of the occluding device, the most suitable LAA morphology for successful occlusion would be expected to be the sphere-like-shaped LAA, because of its narrow orifice diameter compared with the maximal width or inner diameter. In the present study, most of the patients with AF had tube-shaped LAAs, but these would also be expected to be successfully occluded, as would tadpole-and claw-shaped LAAs, based on their morphology. In contrast, LAA occlusion would be expected to be difficult in sword-, willow-leaf-, duckbill-and irregularshaped LAAs because their orifice diameters are larger than those of the maximal width or inner diameter of the LAA, and a large occluding device would be required to achieve successful closure.
There were several limitations to the present study. Participants were only selected from AF patients scheduled for treatment with radiofrequency catheter ablation and ASD patients scheduled for treatment with catheter occlusion. The study only examined 75 patients and did not include healthy control subjects. In addition, it would have been useful to compare the distribution difference between healthy people and those • Received for publication 20 February 2012 • Accepted subject to revision 31 March 2012
• Revised accepted 16 June 2012 Copyright © 2012 Field House Publishing LLP with AF. To avoid performing trans-septal punctures in healthy people, ASD patients were recruited as the comparison group, because trans-septal punctures were unnecessary in these patients. We did not consider that comparing the distribution differences between AF and ASD patients would have revealed any significant findings. Further studies need to include larger numbers of patients and more patients with AF, not merely those scheduled for radiofrequency catheter ablation procedures; such studies would also benefit from assessment of inter-and intraobserver variability.
In conclusion, the LAAs demonstrated considerable morphological variability in terms of the size, shape and the number of lobes. The majority of patients with AF had tube-shaped LAAs with a single lobe, and the two most common LAA shapes in patients with ASD were sphere-like or irregular, with two or more lobes. There were also significant differences in the physical dimensions of the LAAs observed between the two groups of patients. AF may lead to dilatation of the LAA, and occluding devices need to take into account the size and shape of LAAs in Chinese patients with AF.
